The Molecular Basis of Insomnia: Implication for Therapeutic Approaches
Authors:
- 4 September 2016
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 77 (8) , 427-436
Abstract
Preclinical Research Insomnia is one of the most common sleep disorders that is characterized by difficulty in sleep initiation, sleep maintenance, and/or poor sleep quality. Treatment for insomnia includes both pharmacological and non‐pharmacological interventions. Recently, the development of pharmacological treatment for insomnia has been prompted by the understanding of the molecular neurobiology of sleep‐wake regulation. For pharmacological treatment, benzodiazepines that target GABAergic system are the most widely used hypnotics. Besides GABA, the hypocretin/orexin system, and the hypothalamic–pituitary–adrenal (HPA) axis are involved in sleep‐wake regulation and may also play important role in the pathogenesis of insomnia. Genetic studies have revealed the critical role of several important genes related to the above‐mentioned systems in the regulation and function of sleep, suggesting the genetic/epigenetic factors could also contribute to the development and regulation of insomnia. Non‐pharmacological interventions include cognitive behavioral therapy for insomnia (CBT‐I) that is an effective insomnia treatment with less risk and side effects of drug therapy. Here the current treatments for insomnia based on the molecular mechanisms underlying sleep‐wake regulation, were reviewed and some newer targets that may be beneficial in the development of new treatments for insomnia were discussed. Drug Dev Res 77 : 427–436, 2016.Keywords
This publication has 141 references indexed in Scilit:
- Influences of early shift work on the diurnal cortisol rhythm, mood and sleep: Within-subject variation in male airline pilotsPsychoneuroendocrinology, 2013
- Pharmacodynamic Considerations for Moderate and Deep SedationAnesthesia Progress, 2012
- Genetics of Sleep and Sleep DisordersCell, 2011
- Sleep State SwitchingNeuron, 2010
- Role of 5-HT2A receptor antagonists in the treatment of insomniaNature and Science of Sleep, 2010
- Genetic analysis of sleepGenes & Development, 2010
- Neural Circuitry of Stress-Induced Insomnia in RatsJournal of Neuroscience, 2008
- Structural Mechanisms Underlying Benzodiazepine Modulation of the GABAAReceptorJournal of Neuroscience, 2008
- The Efficacy and Safety of Drug Treatments for Chronic Insomnia in Adults: A Meta-analysis of RCTsJournal of General Internal Medicine, 2007
- Chronic Insomnia and the Stress SystemSleep Medicine Clinics, 2007